EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
ImageneBio Inc
IMA

IMA ImageneBio Inc

ImageneBio Inc · NASDAQ
Market Closed
4.89
▼ ⁦-2.59%⁩ (-0.13)
Market Cap$55.2M
Beta0.77
52w Low52w High
3.949.47
Last Week
⁦-2.40%⁩
Last Month
⁦-16.27%⁩
Last 3 Months
⁦-13.45%⁩
Last Year
⁦-42.13%⁩
EL7 Factor Analysis
How we score this
Overall6
Poor — bottom quartile of the marketFalling StarF 2/8Better than 6% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
3
—17.6xBottom tier
▸
Growth
29
-100.0%▼7.1%Bottom tier
▸
Quality
100
—4.5%Top tier
▸
Safety
59
—2.6xAround median
▸
Capital Return
78
—2.15%Top tier
▸
Momentum
20
-30.9%▼2.3%Bottom tier
▸
Sentiment
36
4▲3Bottom tier

Frequently Asked Questions

What is ImageneBio Inc stock?▼

ImageneBio Inc is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in ImageneBio Inc?▼

You can buy ImageneBio Inc shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating ImageneBio Inc?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does ImageneBio Inc pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in ImageneBio Inc?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$4.89
Analyst target · 2 analysts
$1.33
⁦-73%⁩
See it clearly overvalued
Range ⁦$1.33–$1.33⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$1.33
⁦-72.8%⁩
Current Price $4.89·Median $1.33
Low
$1.33
High
$1.33
Street summary

ImageneBio (IMA) Price Target Analysis

Bearish tilt

ImageneBio stock shows a sharp negative gap between its current price of 4.96 and the analysts' average target of 1.33, indicating expectations for a substantial decline. Although a new analyst joined the coverage over the past 30 days, bringing the total to two, the price target remained unchanged at 1.33 with zero Dispersion among estimates, reflecting a complete consensus among analysts on a valuation significantly lower than the current market price.

As of 2026-09-02
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.50
Buy
Analyst coverage
⁦4 (+1)⁩
New coverage
Buy conviction
75%
High
Target dispersion
0%
Analyst ratings over time4 analysts rating
3
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.33 → 3.50
Recent analyst moves
  • = Reiterate2026-08-21
    H.C. Wainwright
    Buy
  • ⬇ Downgrade2025-11-25
    Wedbush
    NeutralUnderperform
  • = Reiterate2024-05-29
    TD Cowen
    Buy
Premium content
Financial Analysis
|